跳至主要内容
临床试验/NCT07482228
NCT07482228招募中不适用

Long-Term Cardiovascular and Cerebrovascular Outcomes After Retinal Artery Occlusion: A Nationwide Study

Chonnam National University Hospital1 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2026年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
15,000
试验地点
1
主要终点
Occurrence of MACCE

研究概览

简要总结

Retinal artery occlusion (RAO) is a rare but vision-threatening vascular disorder that is commonly caused by embolic events originating from the heart or carotid arteries. Patients with RAO are known to have an increased risk of subsequent cardiovascular and cerebrovascular events, including ischemic stroke and myocardial infarction. However, long-term outcomes and optimal medical treatment strategies for these patients remain insufficiently characterized.

The purpose of this nationwide population-based study is to investigate the incidence of long-term cardiovascular and cerebrovascular outcomes in patients diagnosed with retinal artery occlusion using the Korean National Health Insurance Service (NHIS) database. In addition, the study aims to evaluate the impact of various medical therapies, including antiplatelet agents, anticoagulants, and statins, on long-term clinical outcomes.

详细描述

Retinal artery occlusion (RAO) is an acute retinal vascular disease that results in sudden and severe vision loss. RAO is typically classified into central retinal artery occlusion (CRAO) and branch retinal artery occlusion (BRAO), depending on the site of arterial obstruction. CRAO generally has a worse clinical prognosis compared with BRAO.

Previous studies have demonstrated that RAO is associated with systemic vascular diseases and an increased risk of ischemic stroke and other cardiovascular events. Despite its clinical significance, effective evidence-based treatment strategies for RAO remain unclear.

This study aims to evaluate the epidemiology and long-term cardiovascular outcomes of patients with RAO in Korea using the National Health Insurance Service (NHIS) database, which covers nearly the entire Korean population. Patients newly diagnosed with RAO between January 2010 and December 2024 will be identified.

This nationwide population-based study may help clarify the long-term prognosis of RAO and identify optimal medical treatment strategies for improving clinical outcomes in these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients newly diagnosed with retinal artery occlusion

排除标准

  • Patients with a prior diagnosis of retinal artery occlusion before the study period.
  • Patients diagnosed with giant cell arteritis.

研究组 & 干预措施

Patients who underwent retinal artery occlusion

Among the total cohort, patients who underwent retinal artery occlusion were selected.

干预措施: retinal artery occlusion (Other)

Matched cohort

Among the total cohort, 1:6 age- and sex-matched subjects without retinal artery occlusion using a propensity score were generated.

结局指标

主要结局

Occurrence of MACCE

时间窗: up to 5 years

major adverse cardiovascular and cerebrovascular event

次要结局

  • Occurrence of all-cause death(up to 5 years)
  • Occurrence of cardiac death(up to 5 years)
  • Occurrence of myocardial infarction(up to 5 years)
  • Occurrence of stroke(up to 5 years)
  • Occurrence of revascularization(up to 5 years)
  • Occurrence of admission due to heart failure(up to 5 years)
  • Occurrence of atrial fibrillation(up to 5 years)
  • Occurrence of major and clinically relevant non-major bleeding(up to 5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seung Hun Lee

Associate Professor

Chonnam National University Hospital

研究点 (1)

Loading locations...

相似试验